Enhancement of hybrid-fiber types in rat soleus muscle after clenbuterol administration during hindlimb unloading

被引:5
作者
Picquet, F [1 ]
De-Doncker, L [1 ]
Falempin, M [1 ]
机构
[1] Univ Sci & Technol Lille, IFR 118, UPRES EA 1032, Lab Plast Neuromusculaire, F-59655 Villeneuve Dascq, France
关键词
beta(2) agonist; clenbuterol; soleus; contractile parameters; myosin; immunohistochemistry; simulated; microgravity; countermeasure;
D O I
10.1139/Y04-034
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Our objective was to determine the effects of a clenbuterol (CB) treatment orally administered (2 mg per kg) to rats submitted to 14 days of hindlimb unloading (HU). The morphological and the contractile properties as well as the myosin heavy chain isoforms contained in each fiber type were determined in whole soleus muscles. As classically described after HU, a decrease in muscle wet weight and in body mass associated with a loss of muscular force, an evolution of the contractile parameters towards those of a fast muscle type, and the emergence of fast myosin heavy chain isoforms were observed. The CB treatment in the HU rats helped reduce the decrease in 1) muscle and body weights, 2) force and 3) the proportion of slow fibers, without preventing the emergence of fast myosin isoforms. Clenbuterol induced a complex remodelling of the muscle typing promoting the combination of both slow and fast myosin isoforms within one fiber. To conclude, our data demonstrate that CB administration partially counteracts the effects produced by HU, and they allow us to anticipate advances in the treatment of muscular atrophy.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 44 条
[1]   CLENBUTEROL PREVENTS OR INHIBITS LOSS OF SPECIFIC MESSENGER-RNAS IN ATROPHYING RAT SKELETAL-MUSCLE [J].
BABIJ, P ;
BOOTH, FW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (05) :C657-C660
[2]  
BONAVENTURE LA, 2002, AM J PHYSIOL-ENDOC M, V282, pE31
[3]   EFFECTS OF CLENBUTEROL ON SKELETAL-MUSCLE MASS, BODY-COMPOSITION, AND RECOVERY FROM SURGICAL STRESS IN SENESCENT RATS [J].
CARTER, WJ ;
DANG, AQ ;
FAAS, FH ;
LYNCH, ME .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (08) :855-860
[4]  
Chen KD, 2001, MUSCLE NERVE, V24, P211, DOI 10.1002/1097-4598(200102)24:2<211::AID-MUS60>3.3.CO
[5]  
2-4
[6]   Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disorders [J].
Desaphy, JF ;
Pierno, S ;
De Luca, A ;
Didonna, P ;
Camerino, DC .
MOLECULAR PHARMACOLOGY, 2003, 63 (03) :659-670
[7]   Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats [J].
Duncan, ND ;
Williams, DA ;
Lynch, GS .
CLINICAL SCIENCE, 2000, 98 (03) :339-347
[8]   BENEFICIAL VERSUS ADVERSE-EFFECTS OF LONG-TERM USE OF CLENBUTEROL IN MDX MICE [J].
DUPONTVERSTEEGDEN, EE ;
KATZ, MS ;
MCCARTER, RJ .
MUSCLE & NERVE, 1995, 18 (12) :1447-1459
[9]  
EDGERTON VR, 1996, HDB PHYSIOL SECT 4, V1, P721
[10]  
Falempin M, 1997, MUSCLE NERVE, V20, P172